In this issue | Nature Reviews Drug Discovery
In this issue | Nature Reviews Drug Discovery"
- Select a language for the TTS:
- UK English Female
- UK English Male
- US English Female
- US English Male
- Australian Female
- Australian Male
- Language selected: (auto detect) - EN
Play all audios:
The dramatic failure of the cholesteryl ester transfer protein inhibitor torcetrapib, designed to raise levels of high-density lipoprotein (HDL) as a treatment for cardiovascular disease, in
2006 raised the question of whether raising HDL is a futile strategy for atheroprotection. This month, Joy and Hegele review the complexity of the HDL system, discuss torcetrapib clinical
trial data, and evaluate alternative strategies for HDL-based therapies. Meanwhile, in this month's perspective, Jia and colleagues suggest that humans can be viewed as “superorganisms with
an indispensable internal ecosystem” — the gut microbiota. The authors propose that systems-oriented technologies such as metabonomics will shed light on complex host–bacteria interactions,
providing novel targets and therapeutic strategies to manipulate gut microbiota associated with disease. The nature of the relationship between humans and members of their microbiome is also
illustrated by the recent elucidation of the role of commensal bacteria in a physiological pathway that converts inorganic nitrate to nitric oxide (NO). In their Review, Lundberg and
colleagues explore the significance of this alternative source of NO, and the possibility of targeting the nitrate–nitrite–NO pathway to treat a diverse range of diseases including
myocardial infarction and stroke. Another simple physiological reaction, the conversion of carbon dioxide to bicarbonate ions and protons catalyzed by carbonic anhydrases (CAs), is also
emerging as a target for a multitude of diseases. CA inhibitors were originally developed as diuretics and antiglaucoma drugs, but Supuran now discusses their emerging potential as
anti-obesity, anticancer and anti-infective drugs. Finally, Klimanskaya and colleagues investigate two key factors that are crucial to the success of stem-cell-based therapies: the ability
to find reliable sources of multipotent and pluripotent cells, and to control their differentiation.
Anyone you share the following link with will be able to read this content:
Trending News
We've got some trouble | 404 - Resource not foundResource not found Error 404 The requested resource could not be found but may be available again in the future....
We've got some trouble | 404 - Resource not foundResource not found Error 404 The requested resource could not be found but may be available again in the future....
We've got some trouble | 404 - Resource not foundResource not found Error 404 The requested resource could not be found but may be available again in the future....
PM Modi offers prayers at Padmanabhaswamy templeModi, who entered the sprawling shrine through the eastern entrance, spent about 20 minutes there Prime Minister Narendr...
User account | Georgia Straight » Vancouver’s source for arts, culture, and eventsUsername * Spaces are allowed; punctuation is not allowed except for periods, hyphens, apostrophes, and underscores. E-m...
Latests News
In this issue | Nature Reviews Drug DiscoveryThe dramatic failure of the cholesteryl ester transfer protein inhibitor torcetrapib, designed to raise levels of high-d...
The page you were looking for doesn't exist.You may have mistyped the address or the page may have moved.By proceeding, you agree to our Terms & Conditions and our ...
Bush to Push Savings Plan to Foster Frugality in U.S.WASHINGTON — The Bush Administration is getting ready to offer a new enticement to encourage Americans to be more thrift...
Los alamitos : harness meet off to rousing startLloyd Arnold sipped a cup of coffee and repeatedly clicked a ballpoint pen as he watched the start of the fourth race on...
Page Not FoundPage Not Found The content that you're looking for is unavailable. You might find what you are looking for by using the ...